[Time to normalization of testosterone after withdrawal of long time LH-RH agonist therapy in prostate cancer].
Kaku
Haruki
H
Department of Urology, Okayama University Graduate School of Medicine and Dentistry.
Tsushima
Tomoyasu
T
Nasu
Yasutomo
Y
Kumon
Hiromi
H
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D004334:Drug Administration Schedule; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D017273:Goserelin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage / Q000009:adverse effects*; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*; D013739:Testosterone / Q000378:metabolism*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; D016729:Leuprolide